Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Turcot syndrome × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 30 Esophageal Squamous Cell Carcinoma 17 Carcinoma, Hepatocellular 16 Squamous Cell Carcinoma of Head and Neck 15 Carcinoma, Non-Small-Cell Lung 15 Triple Negative Breast Neoplasms 12 Breast Neoplasms 11 Uterine Cervical Neoplasms 10 Small Cell Lung Carcinoma 10 Colorectal Neoplasms 10 Melanoma 9 Recurrence 8 Stomach Neoplasms 7 Carcinoma, Renal Cell 7 Head and Neck Neoplasms 5 Carcinoma, Transitional Cell 5 Advanced Solid Tumor 5 Sarcoma 4 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Esophageal Neoplasms 4 Lung Neoplasms 3 Locally Advanced Rectal Cancer 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Urinary Bladder Neoplasms 2

Interventions

pembrolizumab 4 Nivolumab 3 sintilimab 2 Neoadjuvant Therapy 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 denileukin diftitox 1 danvatirsen 1 avelumab 1 atezolizumab 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Ipilimumab 1 Induction Chemotherapy 1 Immunotherapy 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 IMM-101 1 E7777 fusion protein 1 Disulfides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03926338 2025-11-20

PICC

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡